Skip to content

Common Stock at other companies

Eli Lilly logo
Eli LillyLLY
$590M-0.4%
Amgen logo
AmgenAMGN
2.8B0.0%
AbbVie logo
AbbVieABBV
$18M0.0%
Aclaris Therapeutics logo
Aclaris TherapeuticsACRS
$1K0.0%
Avalo Therapeutics logo
Avalo TherapeuticsAVTX
200M0.0%
Vor Biopharma logo
Vor BiopharmaVOR
$19K+46.2%

Other financials

Income statement

See full
Revenue-
Operating income-$15.5M-8.0%
Net income-$14.8M-7.8%
EPS (diluted)-$0.13+51.9%

Balance sheet

See full
Cash & equivalents$90.4M+48.5%
Total debt$2.9M-9.5%
Total equity$95.8M+41.8%
Total assets$102.1M+32.3%

Cash flow

See full
Operating cash flow-$13.4M-11.6%
CapEx$63.0K
Free cash flow-$13.5M-12.1%

Valuation

See full
Market cap$564.45M+1,131%
Enterprise value$476.92M-4,119%
P/S564.5×+554×

Profitability

See full
Operating margin-5,266.4%-9,520pp
Net margin-4,987.4%-8,966pp
FCF margin-4,140.8%-7,144pp

Returns & leverage

See full
Return on equity-61%-8.0pp
Debt / equity0.0×
Current ratio22.1×+13.0×

Where this comes from

Reported directly by Shattuck Labs, Inc. in its filing.

Tagged under the XBRL concept us-gaap:CommonStockSharesAuthorized.

The official record: Shattuck Labs, Inc.’s 10-Q, filed May 7, 2026, on SEC EDGAR. View the filing →

Ask your AI about Shattuck Labs, Inc.'s common stock.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Shattuck Labs, Inc.'s common stock?
Shattuck Labs, Inc. (STTK) reported common stock of 300M in Q1 2026.
How has Shattuck Labs, Inc.'s common stock changed year-over-year?
Shattuck Labs, Inc.'s common stock decreased by 0.0% year-over-year, from 300M to 300M.
What is the long-term trend for Shattuck Labs, Inc.'s common stock?
Over 5 years (2020 to 2025), Shattuck Labs, Inc.'s common stock has grown at a 0.0% compound annual growth rate (CAGR), from 300M to 300M.
What does common stock mean?
The par value of all common shares issued and outstanding, typically a nominal amount ($0.01 or $0.001 per share).